$ELV Earnings Preview: Oversold Potential + Key Metrics AheadEarnings Estimates: Analysts forecast an EPS of $3.82 for the upcoming quarter, indicating a 32% year-over-year decline. Revenue is projected at $44.67 billion, a 5.2% increase from the same period last year.
Oversold Potential: With an oversold score of 59%, NYSE:ELV appears attractive for a
15,300.866
0.029 BRL
32.24 B BRL
953.17 B BRL
About Elevance Health, Inc.
Sector
Industry
CEO
Gail Koziara Boudreaux
Website
Headquarters
Indianapolis
Founded
1944
ISIN
BRE1LVBDR002
FIGI
BBG00R4Z5100
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Elevance - Short interest declining, buy the dip?The shorts have done extremely well here, dragging the price down by over 34%. ELV has been under severe pressure due to a miss on EPS on their last earnings report. However, they did beat on revenue (by $1.58B) but that did not stop holders exiting their positions.
Unless you're living under a she
ELV buying opportunityNYSE:ELV buying opportunity, in my opinion.
Elevance Health, Inc. (ELV), formerly known as Anthem, Inc., is a health benefits company that provides medical, pharmaceutical, dental, behavioral health, and other insurance-related services to its members. It operates through affiliated health plans
ELV - capitalizing on misses from UNH and HUMNYSE:ELV had a great earnings, beating on top and bottom line estimates and following through with a 10% dividend increase. This comes as NYSE:UNH and NYSE:HUM each disappoint and lower guidance.
ELV has put in a strong consolidation after retracing from 2022 highs. Using a fib fan from the 2
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ANTM4983288
Elevance Health, Inc. 3.125% 15-MAY-2050Yield to maturity
7.18%
Maturity date
May 15, 2050
US36752AS2
ELEVANCE HE. 21/51Yield to maturity
7.04%
Maturity date
Mar 15, 2051
ANTM4880736
Elevance Health, Inc. 3.7% 15-SEP-2049Yield to maturity
6.90%
Maturity date
Sep 15, 2049
ANTM4153492
Elevance Health, Inc. 4.85% 15-AUG-2054Yield to maturity
6.58%
Maturity date
Aug 15, 2054
AE1J
ELEVANCE HE. 17/47Yield to maturity
6.56%
Maturity date
Dec 1, 2047
ANTM5405192
Elevance Health, Inc. 4.55% 15-MAY-2052Yield to maturity
6.54%
Maturity date
May 15, 2052
ANTM4606236
Anthem, Inc. /Old/ 4.55% 01-MAR-2048Yield to maturity
6.52%
Maturity date
Mar 1, 2048
ELVH5534305
Elevance Health, Inc. 5.125% 15-FEB-2053Yield to maturity
6.37%
Maturity date
Feb 15, 2053
ANTM4153493
Elevance Health, Inc. 4.65% 15-AUG-2044Yield to maturity
6.30%
Maturity date
Aug 15, 2044
ANTM5923067
Elevance Health, Inc. 5.85% 01-NOV-2064Yield to maturity
6.28%
Maturity date
Nov 1, 2064
ANTM3851462
Elevance Health, Inc. 4.625% 15-MAY-2042Yield to maturity
6.23%
Maturity date
May 15, 2042
See all E1LV34 bonds